PUBLISHED DATE : Nov 2020 | Pages : 286
Fill out your details & get your free sample
Neural Implants Market Size, Share, Trends Analysis Report by End-users (Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers), Products (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)), Application (Chronic Pain, Parkinson’s Disease (PD), Epilepsy, and others), and Geography (APAC, North America, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025
286 Pages
61 Tables
134 Charts
5 Regions
19 Countries
18 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 7.2 Billion (2025) |
| CAGR | 11% (2020–2025) |
| Base Year | 2019 |
| Forecast Year | 2020–2025 |
| Market Segments | End-users (Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers), Products (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)), Application (Chronic Pain, Parkinson’s Disease (PD), Epilepsy, and others) |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, Turkey, South Africa, UAE, and Saudi Arabia |
The global neural implants or brain implants market size to cross over USD 7.2 billion by 2025, growing at a CAGR of close to 11% during the forecast period. The global brain implants market is one of the fastest-growing segments in the global neurological treatment devices industry. The growing prevalence of neurological diseases worldwide, coupled with rising awareness among patients about new treatment modalities for neurological disorders and the increasing availability of effective devices, is a major factor contributing to the industry growth. Neural implant technology is highly innovative and is expected to influence the existing treatment modalities of neuropathic disorders and chronic neuropathic pain. The introduction of neural implants has been a significant breakthrough in neurological treatment modalities with their high potential in minimizing the occurrence of adverse events associated with Parkinson’s Disease, chronic pain, epilepsy, and other neural disorders. Therefore, the adoption of neural implants is likely to increase at a phenomenal rate in the coming years.
With the outbreak of the COVID-19 pandemic, the global neural implants market witnessed a decline in demand in the first quarter of 2020. Many non-critical surgeries are postponed or delayed in the virus affected countries as most HCPs have been redeployed to critical departments to tackle the pandemic. Further, the utilization of neuromodulation procedures with neural implants is likely to decline in 2020 as the number of surgical procedures is estimated to decrease in the short term, therefore delaying the new purchase of these devices until the COVID-19 pandemic subsides.
This research report includes a detailed segmentation by
In 2019, the spinal cord stimulation (SCS) segment accounted for more than 62% of the global neural implants market share. The growth of the segment has been fueled primarily due to the increasing prevalence of neuropathic pain, particularly the upsurge of patients with failed back surgery syndrome (FBSS)/failed back syndrome (FBS), and the attempts to use strategies other than chronic opioid therapy for the treatment of chronic neuropathic pain. Implantable SCS systems are used to treat certain types of chronic pain, such as neuropathic pain. As an intervention for chronic pain, SCS has proven an effective alternative.
The deep brain stimulation (DBS) segment is expected to grow at a CAGR of close to 10% during 2019–2025. DBS is an effective treatment for common movement disorders and has been effective in modulating neural activity by delivering electrical stimulation to key brain structures. The long-term efficacy of stimulation in treating disorders dystonia, and essential tremors, has encouraged the application to a wide range of neurological and psychiatric conditions.
The chronic pain segment will cross USD 4 billion by 2025. According to the WHO, an estimated 22% of the world’s primary care patients have chronic debilitating pain making chronic pain a global challenge to be addressed by healthcare professionals. The incidence/prevalence of chronic pain is increasing rapidly worldwide. It affects 28−65% of the population in the US. Developing countries face a large burden of chronic pain than developed regions. Thus, the rising burden of chronic pain is likely to fuel the growth of the segment.
In 2019, the Parkinson's disease (PD) segment accounted for 20% of the market share. The growing geriatric population worldwide is one of the key factors placing more adults at risk of PD.
In 2019, hospitals' end-user segment constituted over 56% of the global neural implants market share. Healthcare professionals in hospitals are using neural implants for treating symptoms associated with neuropathic pain and neurodegenerative disorders. The industry is growing at a healthy rate and is likely to grow during the forecast period. The high adoption of the latest generation implants and the increased preference among patients with an increased risk of neurological diseases for visiting hospitals for diagnosis and treatment contribute to the segment's growth.
The specialized neurological center segment will grow because of the availability of sophisticated infrastructure related to the diagnosis and treatment of neurological disorders in specialized neurological centers.
The North America neural implants market will reach over USD 5 billion by 2025. The industry is expected to witness lucrative growth during the forecast period due to the rising technological advancements that influence the uptake of easy-to-use medical devices. The increased healthcare spending is further leading to the neural implants market growth in the region. The region is the single largest market for brain implants, becoming strategically important for several prominent market players such as Medtronic, Abbott, Boston Scientific, and others. Therefore, North America is witnessing a substantial number of product approvals over several years. The region is characterized by high penetration of advanced treatment solutions for neurological diseases. With favorable patient demography and the aging population, the region offers tremendous growth opportunities. Thereby the brain implants market is expected to continue to grow during the forecast period.
The global neural implants market share is highly consolidated, with major vendors accounting for dominant shares. Key vendors are offering a broad range of conventional as well as latest-generation neural implants for end-users. Medtronic, Abbott, Boston Scientific, NEVRO, and LivaNova are the key players in the industry. These vendors compete based on technology advances, accuracy features, regulatory approvals, marketing strategies, and distribution channels. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on product innovation, strategic mergers & acquisitions, and R&D activities.
By Product
By Application
By End-user
By Geography
Frequently Asked Questions
What is the neural implants market size and growth rate during the forecast period?
The global neural implants market size to reach close to USD 7.2 billion by 2025, growing at a CAGR of close to 11% during 2020-2025
What are the factors affecting industry growth?
The emergence of latest generation devices & technology and the promising rise of investigational Devices are expected to drive the market.
What is the growth of the APAC neural implants market during the forecast period?
The APAC neural implants market is expected to observe an incremental growth of over $440 million by 2025.
Who are the leading vendors in the global neural implants market?
The leading vendors in the global neural implants market are Medtronic, Abbott, Boston Scientific, and NEVRO are the key industry players.
The neural implants market by revenue is expected to grow at a CAGR of ≈11% during the period 2020–2025.
The following factors are likely to contribute to the growth of the neural implants market during the forecast period:
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the neural implants market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Prominent Vendors
Other Prominent Vendors
Investigational Companies
By Product
By Application
By End-user
By Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the Study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Application
4.4.3 Market Segmentation by End-user
4.4.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Neural Implants: An Overview
7.1.1 Background
7.1.2 Clinical Use of Neural implants
7.1.3 Neural Implants: Market Snapshot
8 Market Opportunities & Trends
8.1 Emergence of Latest Generation Neural Implants
8.2 Promising Investigational Devices
8.3 New Product Approvals/Launches
9 Market Growth Enablers
9.1 Rising Target Patient Pool Globally
9.2 Growing Popularity of MR-Conditional Neural Implants
9.3 Increasing Uptake of Minimally Invasive Pain Relief Treatment
9.4 Use of High-Frequenecy Neuromodulation Therapy
10 Market Restraints
10.1 Risks & Complications Associated With Neural Implants
10.1.1 Complications Associated with DBS
10.1.2 Complications Associated with SCS
10.1.3 Complications Associated with VNS
10.2 Stringent Regulations Associated With Neural Implants
10.3 Limited Availability of Skilled Neurologists/Neurosurgeons
10.4 High Cost of Neural Implants
11 Market Landscape
11.1 Market Overview
11.2 COVID-19 Impact on the Global Neural Implants Market
11.3 Market Size & Forecast
11.4 Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Neural Implants Market by Product
12.1 Snapshot & Growth Engine
12.2 Overview
12.3 SCS
12.3.1 Overview
12.3.2 Size & Forecast
12.3.3 Geography Segmentation: Snapshot & Growth Engine
12.4 DBS
12.4.1 Overview
12.4.2 Size & Forecast
12.4.3 Geography Segmentation: Snapshot & Growth Engine
12.5 VNS
12.5.1 Overview
12.5.2 Size & Forecast
12.5.3 Geography Segmentation: Snapshot & Growth Engine
13 Neural Implants Market by Application
13.1 Snapshot & Growth Engine
13.2 Overview
13.3 Chronic Pain
13.3.1 Overview
13.3.2 Size & Forecast
13.4 Parkinson’s Disease
13.4.1 Overview
13.4.2 Size & Forecast
13.5 Epilepsy
13.5.1 Overview
13.5.2 Size & Forecast
13.6 Others
13.6.1 Overview
13.6.2 Size & Forecast
14 Neural Implants Market by End-User
14.1 Snapshot & Growth Engine
14.2 Overview
14.3 Hospitals
14.3.1 Overview
14.3.2 Size & Forecast
14.4 Specialized Neurological Centers
14.4.1 Overview
14.4.2 Size & Forecast
14.5 Outpatient Surgery Centers
14.5.1 Overview
14.5.2 Size & Forecast
15 Neural Implants Market by Geography
15.1 Snapshot & Growth Engine
15.2 Geographic Overview
16 North America
16.1 Overview
16.2 Size & Forecast
16.3 North America: Product Segmentation
16.3.1 Snapshot & Growth Engine
16.4 Key Countries
16.4.1 US: Neural Implants Market Size & Forecast
16.4.2 Canada: Size & Forecast
17 Europe
17.1 Overview
17.2 Size & Forecast
17.3 Europe: Product Segmentation
17.3.1 Snapshot & Growth Engine
17.4 Key Countries
17.4.1 Germany: Neural Implants Market Size & Forecast
17.4.2 France: Size & Forecast
17.4.3 UK: Neural Implants Market Size & Forecast
17.4.4 Italy: Size & Forecast
17.4.5 Spain: Neural Implants Market Size & Forecast
18 APAC
18.1 Overview
18.2 Size & Forecast
21.3 APAC: Product Segmentation
21.3.1 Snapshot & Growth Engine
18.4 Key Countries
18.4.1 Japan: Neural Implants Market Size & Forecast
18.4.2 China: Size & Forecast
18.4.3 Australia: Neural Implants Market Size & Forecast
18.4.4 South Korea: Size & Forecast
18.4.5 India: Neural Implants Market Size & Forecast
19 Latin America
19.1 Overview
19.2 Size & Forecast
19.3 Latin America: Product Segmentation
19.3.1 Snapshot & Growth Engine
19.4 Key Countries
19.4.1 Brazil: Neural Implants Market Size & Forecast
19.4.2 Mexico: Size & Forecast
19.4.3 Argentina: Neural Implants Market Size & Forecast
20 Middle East & Africa
20.1 Overview
20.2 Size & Forecast
20.3 Middle East & Africa: Product Segmentation
20.3.1 Snapshot & Growth Engine
20.4 Key Countries
20.4.1 Turkey: Neural Implants Market Size & Forecast
20.4.2 Saudi Arabia: Size & Forecast
20.4.3 South Africa: Neural Implants Market Size & Forecast
20.4.4 Iran: Market Size & Forecast
21 Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Medtronic
21.2.2 Boston Scientific
21.2.3 Abbott
21.2.4 LivaNova
21.2.5 NEVRO
22 Key Company Profiles
22.1 Medtronic
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 Abbott
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 Boston Scientific
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 NEVRO
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 LivaNova
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities
23 OTHER PROMINENT VENDORS
23.1 Aleva Neurotherapeutics
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Beijing PINS Medical
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Nalu Medical
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 NeuroPace
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Nuvectra
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 Saluda Medical
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
23.7 SceneRay
23.7.1 Business Overview
23.7.2 Product Offerings
23.7.3 Key Strategies
23.7.4 Key Strengths
23.7.5 Key Opportunities
23.8 Stimwave
23.8.1 Business Overview
23.8.2 Product Offerings
23.8.3 Key Strategies
23.8.4 Key Strengths
23.8.5 Key Opportunities
24 Investigational Companies
24.1 GTX Medical
24.1.1 Business Overview
24.1.2 Investigational Products
24.2 MicroTransponder
24.2.1 Business Overview
24.2.2 Investigational Products
24.3 Neuralink
24.3.1 Business Overview
24.3.2 Investigational Products
24.4 SetPoint Medical
24.4.1 Business Overview
24.4.2 Investigational Products
24.5 Synchron
24.5.1 Business Overview
24.5.2 Investigational Products
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 Product
26.2 Application
26.3 End-User
26.4 Geography
26.5 North America: Product Segmentation
26.6 Europe: Product Segmentation
26.7 APAC: Product Segmentation
26.8 Latin America: Product Segmentation
26.9 Middle East & Africa: Product Segmentation
26.1 SCS: Geography Segmentation
26.11 DBS: Geography Segmentation
26.12 VNS: Geography Segmentation
27 Appendix
27.1 Abbreviations
Exhibit 1 Segmentation of Global Neural Implants Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Types of Neural Implant Devices
Exhibit 4 Global Neural Implants Market by Geography 2019 (%)
Exhibit 5 Global Neural Implants Market by Product 2019 (%)
Exhibit 6 Impact of Emergence of Latest Generation Neural Implants
Exhibit 7 Impact of Promising Investigational Devices
Exhibit 8 Impact of New Product Approvals/Launches
Exhibit 9 Impact of Rising Target Patient Pool Globally
Exhibit 10 Parkinson's Disease Death Rate in US 2010−2017 (per 100,000 population)
Exhibit 11 Number of Epilepsy Cases Worldwide by Region 2016
Exhibit 12 Impact of Growing Popularity of MR-conditional Neural Implants
Exhibit 13 Impact of Increasing Uptake of Minimally Invasive Pain Relief Treatment
Exhibit 14 Key Benefits of Minimally Invasive Chronic Pain Management with SCS
Exhibit 15 Impact of Use of High-Frequency Neuromodulation Therapy
Exhibit 16 Key Benefits of Paresthesia-free Therapy over Traditional SCS Treatment
Exhibit 17 Impact of Risks & Complications Associated with Neural Implants
Exhibit 18 Potential Complications Related to DBS
Exhibit 19 Potential Complications Related to SCS
Exhibit 20 Impact of Stringent Regulations Associated with Neural Implants
Exhibit 21 Key Recommendations to Healthcare Providers by FDA for SCS
Exhibit 22 Major Actions/Sanctions Imposed on Manufacturers by Regulatory Bodies
Exhibit 23 Impact of Limited Availability of Skilled Neurologists/Neurosurgeons
Exhibit 24 Impact of High Cost of Neural Implants
Exhibit 25 Key Factors Affecting the Cost of DBS Procedure
Exhibit 26 Global Neural Implants Market 2019–2025 ($ million)
Exhibit 27 Global Neural Implants Market by Geography
Exhibit 28 Global Neural Implants Market by Product
Exhibit 29 Global Neural Implants Market by Application
Exhibit 30 Global Neural Implants Market by End-user
Exhibit 31 Five Forces Analysis 2019
Exhibit 32 Incremental Growth by Product 2019 & 2025
Exhibit 33 Global Neural Implants Market by Product
Exhibit 34 Global Market by Product: Incremental Growth
Exhibit 35 Global Market by Product: Absolute Growth
Exhibit 36 Global Neural Implants Market by SCS: Incremental & Absolute Growth
Exhibit 37 Potential Benefits Offered by SCS
Exhibit 38 Global Market by SCS 2019–2025 ($ million)
Exhibit 39 Incremental Growth by Geography 2019 & 2025
Exhibit 40 Global Neural Implants Market by DBS: Incremental & Absolute Growth
Exhibit 41 Global Market by DBS 2019–2025 ($ million)
Exhibit 42 Incremental Growth by Geography 2019 & 2025
Exhibit 43 Global Neural Implants Market by VNS: Incremental & Absolute Growth
Exhibit 44 The FDA Approved Indications for VNS in Adults
Exhibit 45 Global Market by VNS 2019–2025 ($ million)
Exhibit 46 Incremental Growth by Geography 2019 & 2025
Exhibit 47 Incremental Growth by Application 2019 & 2025
Exhibit 48 Global Neural Implants Market by Application
Exhibit 49 Global Market by Application: Incremental Growth
Exhibit 50 Global Market by Application: Absolute Growth
Exhibit 51 Global Neural Implants Market by Chronic Pain: Incremental & Absolute Growth
Exhibit 52 Global Market by Chronic Pain 2019–2025 ($ million)
Exhibit 53 Global Neural Implants Market by PD: Incremental & Absolute Growth
Exhibit 54 Global Market by PD 2019–2025 ($ million)
Exhibit 55 Global Neural Implants Market by Epilepsy: Incremental & Absolute Growth
Exhibit 56 Global Market by Epilepsy 2019–2025 ($ million)
Exhibit 57 Global Neural Implants Market by Others: Incremental & Absolute Growth
Exhibit 58 Global Market by Others 2019–2025 ($ million)
Exhibit 59 Incremental Growth by End-user 2019 & 2025
Exhibit 60 Global Neural Implants Market by End-user
Exhibit 61 Global Market by End-user: Incremental Growth
Exhibit 62 Global Market by End-user: Absolute Growth
Exhibit 63 Global Neural Implants Market by Hospitals: Incremental & Absolute Growth
Exhibit 64 Global Market by Hospitals 2019–2025 ($ million)
Exhibit 65 Global Neural Implants Market by Specialized Neurological Centers: Incremental & Absolute Growth
Exhibit 66 Global Market by Specialty Neurological Centers 2019–2025 ($ million)
Exhibit 67 Global Neural Implants Market by Outpatient Surgery Centers: Incremental & Absolute Growth
Exhibit 68 Global Market by Outpatient Surgery Centers 2019–2025 ($ million)
Exhibit 69 Incremental Growth by Geography 2019 & 2025
Exhibit 70 Global Neural Implants Market by Geography
Exhibit 71 Global Market by Geography 2019: Key Countries ($ million)
Exhibit 72 Global Market by Geography: Incremental Growth
Exhibit 73 Global Market by Geography: Absolute Growth
Exhibit 74 North America Neural Implants Market in 2019
Exhibit 75 North America Market: Absolute & Incremental Growth
Exhibit 76 Market in North America 2019–2025 ($ million)
Exhibit 77 Incremental Growth by Product 2019 & 2025
Exhibit 78 Incremental Growth in North America 2019 & 2025
Exhibit 79 Percentage of PD patients who Utilized Several Resources to Manage PD in US (2019)
Exhibit 80 Market in US 2019–2025 ($ million)
Exhibit 81 Market in Canada 2019–2025 ($ million)
Exhibit 82 Europe Neural Implants Market in 2019
Exhibit 83 Market in Europe: Incremental & Absolute Growth
Exhibit 84 Market in Europe 2019–2025 ($ million)
Exhibit 85 Incremental Growth by Product 2019 & 2025
Exhibit 86 Incremental Growth in Europe 2019 & 2025
Exhibit 87 Market in Germany 2019–2025 ($ million)
Exhibit 88 Market in France 2019–2025 ($ million)
Exhibit 89 Market in UK 2019–2025 ($ million)
Exhibit 90 Market in Italy 2019–2025 ($ million)
Exhibit 91 ants Market in Spain 2019–2025 ($ million)
Exhibit 92 APAC Neural Implants Market in 2019
Exhibit 93 APAC Market: Incremental & Absolute Growth
Exhibit 94 Market in APAC 2019–2025 ($ million)
Exhibit 95 Population Demographics in APAC
Exhibit 96 Health Access & Quality Index Score for Key APAC Countries 2016
Exhibit 97 Incremental Growth by Product 2019 & 2025
Exhibit 98 Incremental Growth in APAC 2019 & 2025
Exhibit 99 Market in Japan 2019–2025 ($ million)
Exhibit 100 Market in China 2019–2025 ($ million)
Exhibit 101 Market in Australia 2019–2025 ($ million)
Exhibit 102 Market in South Korea 2019–2025 ($ million)
Exhibit 103 Market in India 2019–2025 ($ million)
Exhibit 104 Latin America Neural Implants Market in 2019
Exhibit 105 Market in Latin America: Incremental & Absolute Growth
Exhibit 106 Market in Latin America 2019–2025 ($ million)
Exhibit 107 Incremental Growth by Product 2019 & 2025
Exhibit 108 Incremental Growth in Latin America 2019 & 2025
Exhibit 109 Market in Brazil 2019–2025 ($ million)
Exhibit 110 Market in Mexico 2019–2025 ($ million)
Exhibit 111 Market in Argentina 2019–2025 ($ million)
Exhibit 112 Middle East & Africa Neural Implants Market in 2019
Exhibit 113 Middle East & Africa Market: Incremental & Absolute Growth
Exhibit 114 Market in Middle East & Africa 2019–2025 ($ million)
Exhibit 115 Incremental Growth by Product 2019 & 2025
Exhibit 116 Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 117 Market in Turkey 2019–2025 ($ million)
Exhibit 118 Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 119 Market in South Africa 2019–2025 ($ million)
Exhibit 120 Market in Iran 2019–2025 ($ million)
Exhibit 121 Global Neural Implants Market: Vendors Market Share (2019)
Exhibit 122 Medtronic: R&D Expenditure 2017−2019 ($ million)
Exhibit 123 Medtronic: Revenue by Segments 2018 & 2019 ($ million)
Exhibit 124 Medtronic: Revenue by Geography 2019 (%)
Exhibit 125 Abbott: R&D Expenditure 2017−2019 ($ million)
Exhibit 126 Abbott: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 127 Abbott: Revenue by Geography 2019 (%)
Exhibit 128 Boston Scientific: R&D Expenditure 2017−2019 ($ million)
Exhibit 129 Boston Scientific: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 130 Boston Scientific: Revenue by Geography 2019 (%)
Exhibit 131 NEVRO: R&D Expenditure 2017−2019 ($ million)
Exhibit 132 NEVRO: Revenue by Geography 2019 (%)
Exhibit 133 LivaNova: R&D Expenditure 2017−2019 ($ million)
Exhibit 134 LivaNova: Revenue by Segment 2018 & 2019 ($ million)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 Key Investigational Neural Implants
Table 4 List of New Product Approvals/Launches
Table 5 Few Key Commercially Available MR Conditional Neural Implants
Table 6 Estimated Health Worker Needs-Based Shortages by Region, 2013 & 2030 (million)
Table 7 Country wise Estimated Cost of DBS Procedure
Table 8 Significant Players Offering SCS Devices
Table 9 Significant Players Offering DBS Devices
Table 10 Significant Players Offering VNS Devices
Table 11 Major Factors Associated with the Development of Chronic Pain
Table 12 Key Neural Implants for Chronic Pain by Significant Players
Table 13 Key Neural Implants for PD Offered by Significant Players
Table 14 Key Neural Implants for Epilepsy Offered by Significant Players
Table 15 Key Neural Implants for Others Offered by Significant Players
Table 16 Provincial Reimbursement Policy in China
Table 17 Typical Cost of DBS including Surgery, Inpatient Stay, and Follow-ups in India Compared to Developed Countries
Table 18 Key Competitive Factors in the Global Neural Implants Market
Table 19 Global Neural Implants Market: Vendors Ranking 2019
Table 20 Medtronic: Major Product Offerings
Table 21 Abbott: Major Product Offerings
Table 22 Boston Scientific: Major Product Offerings
Table 23 NEVRO: Major Product Offerings
Table 24 LivaNova: Major Product Offerings
Table 25 Aleva Neurotherapeutics: Major Product Offerings
Table 26 Beijing PINS Medical: Major Product Offerings
Table 27 Nalu Medical: Major Product Offerings
Table 28 NeuroPace: Major Product Offerings
Table 29 Nuvectra: Major Product Offerings
Table 30 Saluda Medical: Major Product Offerings
Table 31 SceneRay: Major Product Offerings
Table 32 Stimwave: Major Product Offerings
Table 33 GTX Medical: Major Product Offerings
Table 34 MicroTransponder: Major Product Offerings
Table 35 Neuralink: Major Product Offerings
Table 36 SetPoint Medical: Major Product Offerings
Table 37 Synchron: Major Product Offerings
Table 38 Global Neural Implants Market by Product 2019−2025 ($ million)
Table 39 Global Market by Product 2019−2025 (%)
Table 40 Global Neural Implants Market by Application 2019−2025 ($ million)
Table 41 Global Market by Application 2019−2025 (%)
Table 42 Global Neural Implants Market by End-user 2019−2025 ($ million)
Table 43 Global Market by End-user 2019−2025 (%)
Table 44 Global Neural Implants Market by Geography 2019−2025 ($ million)
Table 45 Global Market by Geography 2019−2025 (%)
Table 46 North America Neural Implants Market by Product 2019−2025 ($ million)
Table 47 North America Market by Product 2019−2025 (%)
Table 48 Europe Neural Implants Market by Product 2019−2025 ($ million)
Table 49 Europe Market by Product 2019−2025 (%)
Table 50 APAC Neural Implants Market by Product 2019−2025 ($ million)
Table 51 APAC Market by Product 2019−2025 (%)
Table 52 Latin America Neural Implants Market by Product 2019−2025 ($ million)
Table 53 Latin America Market by Product 2019−2025 (%)
Table 54 Middle East & Africa Neural Implants Market by Product 2019−2025 ($ million)
Table 55 Middle East & Africa Market by Product 2019−2025 (%)
Table 56 SCS Neural Implants Market by Geography 2019−2025 ($ million)
Table 57 SCS Market by Geography 2019−2025 (%)
Table 58 DBS Neural Implants Market by Geography 2019−2025 ($ million)
Table 59 DBS Market by Geography 2019−2025 (%)
Table 60 VNS Neural Implants Market by Geography 2019−2025 ($ million)
Table 61 VNS Market by Geography 2019−2025 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
